# Erythromycin Ethylsuccinate

NDC: 52536-134
Generic name: Erythromycin Ethylsuccinate
Labeler / Manufacturer: Wilshire Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: GRANULE, FOR SUSPENSION
Routes: ORAL
Marketing started: 20160928

FDA application: NDA050207

## Active ingredients

- ERYTHROMYCIN ETHYLSUCCINATE: 200 mg/5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"52536-134"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=52536-134
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f4a3fffd-ce02-450f-bbcc-d425374e3e32